Dolby Laboratories (DLB) Stock Price, News & Analysis

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" DLB shares.
View DLB analyst ratings or view top-rated stocks.

1 analysts have issued 1-year target prices for Dolby Laboratories' stock. Their DLB share price targets range from $98.00 to $98.00. On average, they predict the company's share price to reach $98.00 in the next year. This suggests a possible upside of 25.2% from the stock's current price.
View analysts price targets for DLB or view top-rated stocks among Wall Street analysts.

Dolby Laboratories' stock was trading at $86.18 at the start of the year. Since then, DLB stock has decreased by 9.2% and is now trading at $78.29.
View the best growth stocks for 2024 here.

Dolby Laboratories saw a increase in short interest in March. As of March 31st, there was short interest totaling 1,440,000 shares, an increase of 13.4% from the March 15th total of 1,270,000 shares. Based on an average daily volume of 380,500 shares, the days-to-cover ratio is currently 3.8 days. Currently, 2.5% of the company's shares are sold short.
View Dolby Laboratories' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our DLB earnings forecast.

Dolby Laboratories will be holding an earnings conference call on Thursday, May 2nd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 647-362-9199 with passcode "5587811".

Dolby Laboratories, Inc. (NYSE:DLB) posted its quarterly earnings data on Thursday, February, 1st. The electronics maker reported $0.76 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.14. The electronics maker had revenue of $315.57 million for the quarter, compared to the consensus estimate of $310.98 million. Dolby Laboratories had a trailing twelve-month return on equity of 10.21% and a net margin of 14.70%.

Dolby Laboratories declared a quarterly dividend on Thursday, February 1st. Investors of record on Tuesday, February 13th will be given a dividend of $0.30 per share on Thursday, February 22nd. This represents a $1.20 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date of this dividend is Monday, February 12th.
Read our dividend analysis for DLB.

Dolby Laboratories (NYSE:DLB) pays an annual dividend of $1.20 per share and currently has a dividend yield of 1.53%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 62.18%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DLB will have a dividend payout ratio of 43.48% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DLB.

ETFs with the largest weight of Dolby Laboratories (NYSE:DLB) stock in their portfolio include ProShares S&P Technology Dividend Aristocrats ETF (TDV), MUSQ Global Music Industry ETF (MUSQ), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), Vanguard U.S. Minimum Volatility ETF (VFMV), WisdomTree U.S. Multifactor Fund (USMF), Mid Cap US Equity Select ETF (RNMC) and American Century Low Volatility ETF (LVOL).

Dolby Laboratories issued an update on its FY 2024 earnings guidance on Thursday, February, 1st. The company provided earnings per share guidance of 3.600-3.750 for the period, compared to the consensus EPS estimate of 3.720. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

253 employees have rated Dolby Laboratories Chief Executive Officer Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

Dolby Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Norris Perne & French LLP MI (0.22%), Alaska Permanent Fund Corp (0.13%), Diversified Investment Strategies LLC (0.06%), Cardinal Capital Management (0.04%), State of Michigan Retirement System (0.02%) and Allspring Global Investments Holdings LLC (0.01%). Insiders that own company stock include Anjali Sud, Avadis Tevanian, Emily Rollins, John D Couling, Kenneth D Knight, Kevin J Yeaman, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Simon Segars, Steven E Forshay, Steven E Forshay and Todd Pendleton.
View institutional ownership trends.

Shares of DLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.